Semaglutide constipation: protocol and timeline
Constipation on semaglutide is similar in mechanism and management to tirzepatide constipation, with a slightly more gradual onset.
The mechanism
Semaglutide slows GI transit through GLP-1 receptor activation. Compared to tirzepatide, the GI effects are slightly less pronounced (no GIP component) but the timeline is longer because the dose ramp is slower. Combined with reduced food + reduced fluid intake, the result is the same chronic constipation pattern most GLP-1 patients experience.
What to expect
Constipation typically emerges weeks 4-8 (slightly later than tirzepatide because of the slower dose ramp). Peaks at the maintenance dose range. By month 4-6, most patients have stabilized into a slower-than-baseline pattern that's manageable with the right protocol.
Management
Same four-part protocol as tirzepatide: targeted hydration, magnesium glycinate before bed, soluble fiber with adequate water, walking after meals. Escalation ladder: docusate sodium, polyethylene glycol (Miralax), prescription options. The slightly slower onset on semaglutide means the protocol is best started prophylactically rather than reactively.
When to escalate
Same as tirzepatide. No bowel movement in 5+ days despite the protocol. Persistent abdominal pain. Blood in stool. Vomiting with inability to pass stool or gas.
- STEP-1 (Wilding et al., NEJM 2021)